Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Plasma cell myeloma

Not yet recruiting

Registered drugNo placebo

Ramantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Hepatitis alcoholic+1

Not yet recruiting

Registered drug

Study on the Safety and Effects of Resatorvid and Filgrastim for Patients with Severe Alcoholic Hepatitis and Acute-on-Chronic Liver Failure

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Filgrastim

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Investigational

Study on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Lanifibranor

Contact Research Centre

Arteriosclerosis

Not recruiting

Registered drug

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Atorvastatin

Contact Research Centre

Acute coronary syndrome

Not recruiting

Registered drug

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Cardiac amyloidosis

Not recruiting

Investigational

Study on the Effects and Safety of Coramitug for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Investigational

Portugal

Participants:18–64 years · 65+ years

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Cardiac amyloidosis

Not recruiting

Registered drugNo placebo

Study on the Effects of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Tafamidis

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Adenocarcinoma gastric

Not recruiting

Registered drugNo placebo

Study of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer After Trastuzumab Treatment

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Paclitaxel

Contact Research Centre

Find therapies in clinical trials near you – page 2

26 trials match your criteria

Plasma cell myeloma

Ramantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant

Hepatitis alcoholic+1

Study on the Safety and Effects of Resatorvid and Filgrastim for Patients with Severe Alcoholic Hepatitis and Acute-on-Chronic Liver Failure

Metabolic dysfunction-associated steatohepatitis+1

Study on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3

Arteriosclerosis

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Acute coronary syndrome

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Colorectal cancer metastatic

Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

Cardiac amyloidosis

Study on the Effects and Safety of Coramitug for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Hormone receptor positive HER2 negative breast cancer

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Squamous cell carcinoma of head and neck

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Cardiac amyloidosis

Study on the Effects of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis

Hepatocellular carcinoma

Study of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)

Adenocarcinoma gastric

Study of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer After Trastuzumab Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.